Jerome A. Chazen

Jerome A. Chazen is a declared insider at 2 companies; the most frequent names are Taubman Centers Inc and Protagenic Therapeutics, Inc.\new. Between 3 January 2006 and 1 October 2018, the trades on record add up to 85 filings.

Both buying and selling appear: 8 purchases worth €2.5M, against 6 sales worth €250k. The net balance comes to €2.3M on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 54 share grants.

A typical purchase (the median) is worth €306k.

On 2 October 2018 came the latest disclosure, a share grant in Taubman Centers Inc. The most recent open-market purchase was published on 17 March 2009, 6,445 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.